Immune support Enhances immune system function and resilience
Be wary of clinics offering unusually low prices, as this may indicate a lack of proper medical training or substandard products
In this randomized trial of more than 9300 subjects with T2DM and high cardiovascular risk, liraglutide was seen to decrease the incidence of the composite cardiovascular primary endpoint (occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke) compared with placebo (13.0 and 14.9% in the liraglutide and placebo group, respectively
Reduced appetite often leads to reduced hydration, which decreases saliva and increases dental risks
Additionally, the review highlights the STRIDE trial in peripheral artery disease, where Semaglutide improved maximum walking distance in people with T2D and PAD, an effect correlated in part with weight loss